For pharmaceutical manufacturers focused on producing high-quality Lisinopril, the selection of intermediates is paramount. Among these, N-6-Trifluoroacetyl-L-lysine (CAS 10009-20-8) stands out as a critical building block. Ensuring the purity and consistent quality of this compound is not merely a preference but a necessity for achieving the desired efficacy and safety profile of the final Active Pharmaceutical Ingredient (API). As a leading supplier of pharmaceutical intermediates, we understand the stringent requirements of the industry and aim to provide reliable access to essential compounds like this lysine derivative.

N-6-Trifluoroacetyl-L-lysine, an N6-acyl-L-lysine derivative, plays a pivotal role in the multi-step synthesis of Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor widely used to treat hypertension and heart failure. The trifluoroacetyl group provides a protective and activating function during specific reaction stages, ultimately contributing to the formation of the complex Lisinopril molecule. Therefore, any impurities or deviations in the quality of N-6-Trifluoroacetyl-L-lysine can have cascading negative effects on downstream synthesis, potentially leading to lower yields, product contamination, and increased purification costs. Pharmaceutical companies globally rely on reputable manufacturers and suppliers who can consistently deliver this intermediate at high purity levels, often exceeding 98%.

When procuring N-6-Trifluoroacetyl-L-lysine, purchasing managers and R&D scientists should prioritize suppliers who can provide comprehensive documentation, including Certificates of Analysis (CoA) detailing assay, impurity profiles, and physical characteristics. Factors such as solubility in specific solvents (like 2 M HCl), melting point, and storage conditions (typically 2-8°C in a dry, dark place) are also important indicators of product quality and stability. Understanding these attributes helps in integrating the intermediate seamlessly into established manufacturing protocols.

As a key player in the fine chemical and pharmaceutical intermediate market, NINGBO INNO PHARMCHEM CO.,LTD. is committed to being a trusted supplier. We offer N-6-Trifluoroacetyl-L-lysine that meets exacting standards, ensuring that your production of Lisinopril and other critical pharmaceuticals is supported by reliable, high-quality materials. By partnering with us, you can streamline your procurement process, secure competitive pricing, and gain access to expert support for your chemical needs. We encourage potential buyers to reach out for quotes and samples, allowing us to demonstrate the quality and service that distinguishes us as a premier chemical manufacturer and exporter.